White House senior adviser Andy Slavitt told reporters on Tuesday that the federal government is planning to spend US$100 million to help the joint partnership between Merck & Co and rival Johnson & Johnson accelerate vaccine production.
Merck & Co will help make rival Johnson & Johnson's single-shot Covid-19 vaccine in a partnership set to be announced on Tuesday by US President Joe Biden, a White House official said. J&J's vaccine production has been slower than promised.